Novo Nordisk (NVO.N) announced that it will nominate pharmaceutical industry veterans Jan van de Winkel and Ramona Sequeira to its board of directors, marking the first personnel change for the Danish obesity drug maker since its restructuring last y

2026-02-20

Novo Nordisk (NVO.N) announced that it will nominate pharmaceutical industry veterans Jan van de Winkel and Ramona Sequeira to its board of directors, marking the first personnel change for the Danish obesity drug maker since its restructuring last year.